Jazz Pharmaceuticals JAZZ and partner PharmaMar announced that they have initiated a phase III confirmatory study — LAGOON — to evaluate Zepzelca in patients with relapsed small cell lung cancer ...
Jazz Pharmaceuticals JAZZ along with partner Zymeworks ZYME announced positive tolerability and efficacy results from an ongoing phase II study on zanidatamab, an investigational HER2-targeted ...
Jazz Pharmaceuticals ((JAZZ)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Zepzelca combo cuts the risk of disease progression or death by 46% and death by 27% vs. Tecentriq alone. Median PFS was 5.4 months with combo vs. 2.1 months with Tecentriq; OS was 13.2 vs. 10.6 ...
The 2024-25 NBA season is in full swing. One month into the new campaign, the Utah Jazz have had to push through cold shooting stretches, absences to key rotation players, and a fairly difficult ...
June 20 (Reuters) - Jazz Pharmaceuticals (JAZZ.O), opens new tab said on Thursday its experimental drug to treat a common movement disorder failed to reduce tremor severity in a mid-stage study, ...
A new year has arrived, but the same NBA regular season continues rolling along. For the Utah Jazz, the month of December brought upon some strides on the offensive end of the floor and a continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback